Cargando…

Colistin monotherapy versus therapy combination

Detalles Bibliográficos
Autores principales:	Charra, B, Benslama, A, Ezzouine, H, Motaouakkil, S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934327/ http://dx.doi.org/10.1186/cc8287

Ejemplares similares

Rifampicin and colistin association in the treatment of severe multiresistant Acinetobacter baumannii infections
por: Charra, B, et al.
Publicado: (2008)

Precocious tracheotomy versus prolonged intubation in a medical ICU
por: Charra, B, et al.
Publicado: (2008)

Intravenous immunoglobulins versus plasma exchange in the treatment of Guillain-Barré syndrome
por: Charra, B, et al.
Publicado: (2009)

Scoring systems (APACHE II and Simplified Acute Physiology Score II) for predicting outcome in status asthmaticus
por: Hachimi, A, et al.
Publicado: (2009)

Immunological manifestations in paraphenylenediamine poisoning
por: Charra, B, et al.
Publicado: (2008)

Contribution of noninvasive ventilation in the precocious extubation in the medical ICU
por: Charra, B, et al.
Publicado: (2009)

Colistin monotherapy versus combination of colistin with a β-lactam or rifampicin for the treatment of serious infections in the ICU due to multidrug-resistant Gram-negative bacteria
por: Tsimogianni, A, et al.
Publicado: (2006)

Intravenous immunoglobulin vs plasma exchange in treatment of mechanically ventilated adults with Guillain-Barré syndrome
por: Charra, Boubaker, et al.
Publicado: (2014)

A randomized trial of combination therapy versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia
por: Heyland, D, et al.
Publicado: (2007)

Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis
por: Huang, Chienhsiu, et al.
Publicado: (2022)

Inhaled ceftazidime and amikacin versus inhaled colistin in the treatment of gram negative ventilator associated pneumonia
por: Nassar, YS, et al.
Publicado: (2015)

Efficacy of Intravenous Colistin Monotherapy Versus Colistin Combined With Meropenem in Patients With Multidrug-Resistant Infections: A Retrospective Observational Study
por: Baig, Mehwish, et al.
Publicado: (2023)

Intravenous fosfomycin therapy in critically ill patients infected with colistin-resistant enterobacteriacae
por: Mukherjee, DN, et al.
Publicado: (2015)

Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant Acinetobacter baumannii Infections: A Preliminary Study
por: Sirijatuphat, Rujipas, et al.
Publicado: (2022)

PARP-1 inhibitor monotherapy and combination therapy in a preclinical mouse model of Brca2 mutant breast cancer
por: Hay, T, et al.
Publicado: (2008)

Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
por: Park, So Yeon, et al.
Publicado: (2019)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019)

Combination Regimens with Colistin Sulfate versus Colistin Sulfate Monotherapy in the Treatment of Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli
por: Hao, Min, et al.
Publicado: (2022)

Optimal dosing interval of intravenous Colistin monotherapy versus combination therapy: A systematic review and meta-analysis
por: Ahmadpour, Forouzan, et al.
Publicado: (2022)

1601. Combination Therapy versus Monotherapy for Carbapenem-resistant Organisms: Is More Really Better?
por: Najia, Laila, et al.
Publicado: (2020)

Lopinavir/ritonavir monotherapy in clinical practice
por: Caso, A, et al.
Publicado: (2010)

AB093. The efficacy of medical treatment of Peyronie’s disease: Potaba monotherapy vs. combination therapy with Tamoxifen, L-carnitine, and PDE5 inhibitor
por: Park, Jong Jin, et al.
Publicado: (2016)

Two consecutive desensitisation protocols in a patient with anaphylaxis to colistin
por: Petrodimopoulou, Maria, et al.
Publicado: (2014)

Inhaled colistin for the treatment of ventilator-associated tracheobronchitis in critically ill patients
por: Athanassa, Z, et al.
Publicado: (2011)

Efficacy and safety of once daily dosing of colistin to critically ill patients
por: Skiada, A, et al.
Publicado: (2010)

Pharmacokinetics of inhaled colistin in critically ill patients with ventilator-associated tracheobronchitis
por: Athanassa, Z, et al.
Publicado: (2012)

Clinical experiment with the use of colistin for the treatment of multiresistant Acinetobacter baumanii nosocomial infection
por: Safi, L, et al.
Publicado: (2009)

Analysis of major and minor IAS-USA PI mutations in the MONET trial of darunavir/ritonavir monotherapy versus DRV/r + 2NRTIs
por: Pulido, F, et al.
Publicado: (2010)

Parenteral colistin for the treatment of severe infections by multidrug-resistant Gram-negative bacteria
por: Grion, C, et al.
Publicado: (2013)

Efficacy and safety of colistin in the treatment of infections in the ICU caused by multidrug-resistant Gram-negative organisms
por: Pavleas, J, et al.
Publicado: (2006)

630. Emergence of Colistin Resistance in the OVERCOME Trial: Impact of Combination Therapy with Meropenem
por: Pogue, Jason M, et al.
Publicado: (2021)

Intrathecal administration of colistin, vancomycin and amikacin for central nervous system infections in ICU neurosurgical patients
por: Alexandropoulos, P, et al.
Publicado: (2015)

272. Clinical Outcomes with Continuation of Combination Antibiotic Therapy versus De-escalation to Monotherapy for Patients with MRSA Bacteremia
por: Nichols, Courtney, et al.
Publicado: (2020)

Intravenous Colistin Monotherapy versus Combination Therapy against Carbapenem-Resistant Gram-Negative Bacteria Infections: Meta-Analysis of Randomized Controlled Trials
por: Cheng, I-Ling, et al.
Publicado: (2018)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy
por: Pepe, Alessia, et al.
Publicado: (2011)

Emergence of isolates that are intrinsically resistant to colistin in critically ill patients: are we selecting them out?
por: Sivakumar, MN, et al.
Publicado: (2015)

Development of MEDI4736, an anti-programmed cell death ligand 1 (PD-L1) antibody, as monotherapy or in combination with other therapies in the treatment of non-small cell lung cancer (NSCLC)
por: Brahmer, Julie, et al.
Publicado: (2014)

Multidrug-resistant Acinetobacter baumannii susceptible only to colistin outbreak in a cardiac surgical intensive care unit
por: Papadopoulos, K, et al.
Publicado: (2007)

204. Clinical Outcomes with Ceftaroline Monotherapy versus Daptomycin-Ceftaroline Combination Therapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Andonie, Gabriela, et al.
Publicado: (2021)

Efficacy of an intravenous colistin regimen in ventilator-associated pneumonia and bacteraemia due to multiresistant Gram-negative bacteria: preliminary results
por: Frantzeskaki, F, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_bpudk80b8pipb1rtlhdsjse3ca